Pavel Rodiukov Email and Phone Number
Pavel Rodiukov work email
- Valid
- Valid
Pavel Rodiukov personal email
Practicing VC investment since 2004, including international activities since 2010.Specialties include full cycle of management of the investment process, starting with deal origination and ending up with hands-on management and trade sale.Board member at several companies (HemaCore, Mitotech, RMI, NovaMedica, InflammX).Involved in established business activities in Russia, North America, Israel and EU.
Bash Today
View- Website:
- bash.today
- Employees:
- 10
-
PartnerBash Today Mar 2016 - PresentMoscow, Russian FederationBash Today is a leading Russian marketplace for creative spaces hourly rental and public events organization. Whether a private party, business event or a master class is on agenda, Bash Today is the best place to choose venue and make associated arrangements for your event (catering, music, etc).
-
Category A ManagerRmi Investments Jul 2022 - Present -
Board ObserverBinx Health Jul 2020 - Jul 2024 -
Board MemberBinx Health Dec 2018 - Jul 2020Trowbridge, EnglandBinx provides a first of its kind, comprehensive digital program that includes evidence-based sexually transmitted infection (STI) testing, counseling, treatment, and follow up in order to increase screening and reduce infections.
-
Board ObserverEpic Sciences │ The Power Of Clarity May 2019 - Jul 2024San Diego, California, United States -
Director GeneralRmi Llc Mar 2018 - Jul 2024Moscow, Moscow, Russia -
Investment DirectorRusnanomedinvest Mar 2012 - Mar 2018Moscow, Moscow, RussiaRMI LLC is the largest Russian VC fund exclusively specialized in the area of Life Sciences, having approximately $380M in committed capital. RMI activities dedicated to achievement of two principal objectives: building a lucrative and well diversified portfolio of foreign investment into startups that develops state-of-the-art technologies for medicine and healthcare and establishment of the Russian pharmaceutical company NovaMedica with product portfolio based on technology transfer from foreign investments by RMI and in-licensing opportunities from other healthcare companies.
-
Board MemberOcunexus Therapeutics Mar 2018 - Jul 2024Greater San Diego AreaOcuNexus Therapeutics is a development stage biopharmaceutical company with novel, proven gap junction channel modulation technologies targeting unmet clinical needs in ophthalmology.
-
Class B DirectorMitotech S.A. Oct 2010 - Jul 2022LuxembourgMitotechw S.A. is a Luxembourg company that was formed for the purpose of the international development of intellectual property of "The Skulachev Ions" project and its further commercialization. Mitotech S.A. accumulates and maintains intellectual property associated with the Skulachev Ions project for jurisdictions outside Russia and CIS countries and conducts clinical trials in the US. -
Board MemberMitotech Llc Sep 2010 - Dec 2020Moscow, RussiaMitotech LLC is an innovative biopharmaceutical company formed in 2010 for management of "The Skulachev Ions" project, which objective is to enter the market with several products for treatment of spectrum of age-related diseases. Products are based on a fundamentally breakthrough mechanism of action that works at a sub-cellular level of mitochondria: by restoring of optimal level of reactive oxygen species for the cellular recovery from oxygenation stress, it was proven possible in various models to cure the whole organism for a number of age-related diseases. In 2012 the company successfully registered its' first product in Russia – Visomitin eye drops for relief from the "dry eye" inflammatory syndrome and entered the Russian Rx-class pharmaceuticals market. Currently the company conducts clinical trials for more indications and markets existing product for treatment of "dry eye". -
Board MemberOcon Medical Mar 2018 - Aug 2020Modiin, IsraelOCON Healthcare develops, manufactures and commercialises innovative women’s health products based on IUB™, its proprietary intrauterine platform. The platform, made of a super-elastic alloy Nitinol, is an ideal carrier for hormone-free contraception and intrauterine drugs. -
Board MemberTrackpore Technology Jun 2009 - Aug 2020Moscow, RussiaTrackpore Technology is a leading firm that develops, produces and markets medical equipment and disposables for afferent therapy of misc. diseases related to blood and cardiovascular system. In 2009 Trackpore Technology started the establishment of an art-class new manufacturing facility "Beta" for production of next-generation technologies in afferent therapy focused on cascade blood plasma filtration and other hi-tech blood treatment techniques, as well as to enter the donor market of blood plasma. "Beta" is also proposed to become capable of mass production of the hi-tech commodity – track-etched membrane with pore sizes ranging from 70 nm to 2 mkm for misc. applications where exists a strong demand for precise and penny-price filtration (ultrafiltration).
-
Board MemberCeltaxsys, Inc. Dec 2018 - Feb 2020Greater Atlanta AreaCeltaxsys is a clinical-stage pharmaceutical development company focused on advancing novel foundational therapies to treat inflammation in rare, orphan designated diseases, with flagship drug candidate aimed at preserving lung function in cystic fibrosis.
-
Board MemberHemacore Apr 2010 - Nov 2014Moscow, Russian FederationHemaCore is a medical devices startup that develops innovative equipment and methods for hematology. HemaCore was founded in 2010 by a group of scientist who invented and patented the Thrombodynamics, a new reliable method for monitoring and prognosis of such blood coagulation disorders as thrombosis, the major cause of heart attacks and strokes, and bleeding (hemophilia).
-
Senior Investment ManagerNm Trust Asset Management; Universal Asset Management Aug 2007 - Jun 2008Moscow, Russian Federation
-
Senior Investment ManagerSistema-Venture Sep 2006 - Aug 2007Moscow, Russian Federation
-
SpecialistSistema-Venture Oct 2004 - Sep 2006Moscow, Russian Federation
Pavel Rodiukov Skills
Pavel Rodiukov Education Details
-
Federal Financial Markets ServiceSertificates Of The 1.0 And 5.0 Series -
Business Administration And Management, General
Frequently Asked Questions about Pavel Rodiukov
What company does Pavel Rodiukov work for?
Pavel Rodiukov works for Bash Today
What is Pavel Rodiukov's role at the current company?
Pavel Rodiukov's current role is Director General at Bash Today.
What is Pavel Rodiukov's email address?
Pavel Rodiukov's email address is pa****@****ndex.ru
What schools did Pavel Rodiukov attend?
Pavel Rodiukov attended Federal Financial Markets Service, Bauman Moscow State Technical University.
What are some of Pavel Rodiukov's interests?
Pavel Rodiukov has interest in Travel (Motor Rally), Sports Cars, History.
What skills is Pavel Rodiukov known for?
Pavel Rodiukov has skills like Venture Capital, Private Equity, Investments, Corporate Finance, Due Diligence, Business Valuation, Capital Markets.
Who are Pavel Rodiukov's colleagues?
Pavel Rodiukov's colleagues are Olga Metalnikova, Juliana Afonso Joao, Юлия Квитко, Анна Ускова.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial